PSYC’s Psychedelic Spotlight Achieves Milestone With 100K+ Page Views in April
- Wall St rises as jobless claims fall; Cigna weighs on healthcare stocks
- Moderna (MRNA) Tops Q2 Street Estimates, Nabs $4.2 Billion from 199 Million Sold Vaccines That Yielded 93% Efficacy Through Six Months
- Oil rises over 1% as Mideast tensions face virus concerns
- Penn National Gaming (PENN) 'Scores' with $2 Billion Deal to Acquire theScore (SCR), Seen as 'Highly Strategic'
- Uber (UBER) Beats Estimates As Higher Labor Spend Drags on Profitability, Analysts Lower PTs but Remain Bullish
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
The leading media platform for the psychedelics industry sees rapid growth
LAKE OSWEGO,OR, May 12, 2021 (GLOBE NEWSWIRE) -- Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) the first publicly traded digital media company within the emerging sector of medicinal psychedelics, is pleased to announce that according to information observed from Google Analytics, the Company’s flagship website, Psychedelic Spotlight, received nearly 105K page views during the month of April, 2021; a record high for the growing digital media platform that the Company contends has become a preeminent leader for news and information within the emerging sector of medicinal psychedelics.
The Company attributes the ongoing steady growth rate for Psychedelic Spotlight to a couple of key factors, which includes the overall interest the industry continues to garner from the general public and mainstream media, as well as the Company’s increase in production of premium industry-focused content which was recently highlighted by the launch of its Spotlight Roundup video series.
“From the insightful and informative editorials produced by our wonderfully talented team of writers, to our podcasts and Spotlight Roundup, we have managed to evolve Psychedelic Spotlight into an industry-recognized leader not only for news and unique content, but as an active ally for medicinal psychedelics,” Said Global Trac Solutions, Inc. CEO, David Flores. “Many of the long-term business initiatives, which includes revenue generation, that we are focused on, are tied directly into our ability to build and establish a large and robust audience for Psychedelic Spotlight. Therefore, as exciting as it is to have hit this milestone, our focus is already set on pushing our growth beyond this and toward several other key milestones that we recognize we must hit in order to deliver as much value as we possibly can into PSYC over the next several years.”
In addition to reaching over 100K page views in April, the Company also contends that Psychedelic Spotlight received more than one million impressions during the month between search and social media platforms.
“These are important times for healing, and psychedelics are playing such a large role in that conversation,” says Jill Ettinger, Director of Content and co-host of the Psychedelic Spotlight podcast. “It’s no surprise that our content continues to reach such a wide audience. People are hungry for information about the growing shift in our healthcare and policies around psychedelic substances. We expect continued growth in our readership as we expand our content to encompass the exciting developments in this emergent market.”
About Global Trac Solutions, Inc. (OTCPink: PSYC)
At Global Trac Solutions we are integrating media, creativity, and technology to develop and deploy thought-provoking ideas and solutions that are fostering and transforming the approach to some of society’s most pressing matters.
PSYC has expressed its intent and commitment to positioning itself at the forefront of the psychedelic revolution and as a resource center for discovering and understanding the latest research and business opportunities surrounding psychedelic inspired medicines. In conjunction with the FDA’s more open-minded approach to psychedelic medicines, and as several major U.S. cities continue to approve the decriminalization of psilocybin, investors are speculating that the psychedelic boom could be bigger than that of cannabis. PSYC is your source for current investment related news specific to psychedelic medicines and cutting-edge research improving overall health, moving this sector into the mainstream.
We believe in a forward-thinking approach that embraces groundbreaking new technology and innovations and through the vision of business development we intend to continue to evolve into these unchartered territories as the industry leaders of the future. We truly are the right TRAC to follow.
Forward-Looking Statements Disclaimer:
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors, including the effect of COVID-19, that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are disclosed on the OTC Markets.com website.
Disclaimer: Global Trac Solutions, Inc. does not in any way encourage or condone the use, purchase, sale or transfer of any illegal substances, nor do we encourage or condone partaking in any unlawful activities. We support a harm reduction approach for the purpose of education and promoting individual and public safety. If you are choosing to use psychedelic substances, please do so responsibly.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Invitation to Tallinna Sadam Investor Conference Webinar for the results of Q2 2021
- Aktia Bank plc’s new Restricted Share Plan
- Topcon Signs Agreement with DDK Positioning to Provide GNSS Hardware for Maritime Market
Create E-mail Alert Related CategoriesGlobe Newswire, Press Releases
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!